Patents by Inventor Richard Gerald Wilde

Richard Gerald Wilde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
    Patent number: 6869955
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I: and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: March 22, 2005
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventor: Richard Gerald Wilde
  • Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
    Patent number: 6642230
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: November 4, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Richard Gerald Wilde, Rajagopal Bakthavatchalam, James Peter Beck, Argyrios Georgious Arvanitis
  • Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
    Publication number: 20030114468
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula (I): 1
    Type: Application
    Filed: November 7, 2001
    Publication date: June 19, 2003
    Inventors: Richard Gerald Wilde, Rajagopal Bakthavatchalam, James Peter Beck, Argyrios Georgios Arvanitis
  • Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
    Publication number: 20030064993
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I: 1
    Type: Application
    Filed: January 29, 2002
    Publication date: April 3, 2003
    Inventor: Richard Gerald Wilde
  • Therapeutic usage of tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
    Patent number: 6399609
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I: and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: June 4, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventor: Richard Gerald Wilde
  • Imidazopyridines for the treatment of neurological disorders
    Patent number: 6362180
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: March 26, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Richard Gerald Wilde, Rajagopal Bakthavatchalam, James Peter Beck, Argyrios Georgious Arvanitis
  • Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
    Patent number: 6143743
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula (I): ##STR1## and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.
    Type: Grant
    Filed: July 2, 1998
    Date of Patent: November 7, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Richard Gerald Wilde, Rajagopal Bakthavatchalam, James Peter Beck, Argyrios Georgious Arvanitis
  • Tetrahydropteridines for treatment of neurological disorders
    Patent number: 6083948
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I: and their use in treating anxiety, depression, and other psychiatric and neurological disorders are disclosed.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: July 4, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventor: Richard Gerald Wilde